Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

The risks of 'miracle' weight loss jabs such as Ozempic, Wegovy and Mounjaro have been laid bare by a landmark study ...

Weight loss jabs such as Wegovy may reduce risk of dementia by easing inflammation in the brain, scientists say. The drugs ...

Khartoum, Mar.20 (Sudanow) -Alkhala is a type of herb, which belongs to the family. It grows naturally in rugged and wild ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...